Functional Luminal Imaging Probe (FLIP) Topography Use in Patients With Scleroderma and Trouble Swallowing

Trial ID or NCT#

NCT03270722

Status

not recruiting iconNOT RECRUITING

Purpose

FLIP topography has been FDA cleared to evaluate a variety of esophageal conditions, but has never been evaluated in patients with scleroderma. The investigators hope to evaluate this technology in patients who have scleroderma and various esophageal symptoms, and compare to non-scleroderma patients.

Official Title

Use of FLIP Topography to Evaluate Esophageal Symptoms in Patients With Scleroderma

Eligibility Criteria

Ages Eligible for Study: 18 Years to 90 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
Inclusion Criteria:
  1. - Must have a clinical indication for upper endoscopy (recruiting patients both with scleroderma and without)
Exclusion Criteria:
  1. - not healthy enough to undergo an upper endoscopy - mass, stricture, ring, or web present on upper endoscopy - history of esophageal cancer - history of esophageal surgery
View All Criteria
Show Less

Investigator(s)

John Clarke
John Clarke
Gastroenterologist, Motility specialist
Clinical Professor, Medicine - Gastroenterology & Hepatology
Nielsen Fernandez-Becker
Nielsen Fernandez-Becker
Gastroenterologist, Celiac disease specialist, Motility specialist
Clinical Associate Professor, Medicine - Gastroenterology & Hepatology
Lorinda Chung
Lorinda Chung
Rheumatologist, Immunologist
Professor of Medicine (Immunology and Rheumatology) and, by courtesy, of Dermatology

Contact us to find out if this trial is right for you.

Contact

John O Clarke, MD
650-736-5555

View on ClinicalTrials.gov